全球淋球菌监测揭示抗菌药物耐药性的常见模式与独特威胁
美国军医大学淋球菌参考实验室及全球新发感染监测计划菌株库分析了2014-2022年收集自全球多个地理区域的962株淋病奈瑟菌分离株的基因组和表型耐药性。既往用于淋球菌感染的抗菌药物耐药率很高,更值得关注的是当前使用抗生素(如广谱头孢菌素和替代治疗药物庆大霉素)耐药性增加。对头孢曲松敏感性降低的分离株占3.6%,对头孢克肟占2.5%,对庆大霉素占15.0%。
要点
- 962株淋球菌中,对头孢曲松敏感性降低者占3.6%,对头孢克肟占2.5%,对庆大霉素占15.0%。
- 既往用于淋球菌感染的抗菌药物耐药率高,当前使用药物耐药性增加值得关注。
- 分离株虽来自多样性有限的人群,但706株(73.4%)具有新多抗原序列型,225株(23.4%)具有新多位点序列型。
核心结论
- 淋球菌对既往使用抗菌药物耐药率高,对当前使用的广谱头孢菌素和庆大霉素耐药性增加最值得关注。
- 持续监测淋病奈瑟菌对监测耐药菌株的流行和全球传播至关重要。
研究设计与样本
- 美国军医大学淋球菌参考实验室及全球新发感染监测计划菌株库接收来自全球多个地理区域的分离株。
- 分析2014-2022年收集的962株分离株的基因组和表型抗菌药物耐药性。
主要发现
- 对头孢曲松敏感性降低的分离株占3.6%,对头孢克肟敏感性降低的占2.5%,对庆大霉素敏感性降低的占15.0%。
- 分离株来自多样性有限的人群,706株(73.4%)显示新多抗原序列型,225株(23.4%)显示新多位点序列型。
局限性
- 分离株收集自多样性有限的人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The rapid emergence of antimicrobial-resistant strains of Neisseria gonorrhoeae threatens treatment options and control efforts. The Uniformed Services University Gonococcal Reference Laboratory and Repository of the Global Emerging Infections Surveillance Program receives isolates from several geographically distinct regions worldwide. We analyzed 962 isolates collected during 2014-2022 for genomic and phenotypic antimicrobial resistance. Resistance to antimicrobial drugs previously used for gonococcal infections was high, but of most concern were increases of resistance to currently used antibiotic drugs, such as extended-spectrum cephalosporins and the alternative antibiotic treatment gentamicin. The percentage of isolates with reduced susceptibility to ceftriaxone was 3.6%, to cefixime was 2.5%, and to gentamicin was 15.0%. Although isolates were collected from populations of limited diversity, 706 (73.4%) of isolates demonstrated novel multiantigen sequence types, and 225 (23.4%) had novel multilocus sequence types. Continued surveillance of N. gonorrhoeae is essential to monitoring the prevalence and spread of resistant organisms worldwide.
引用
- Le Van A, Rahman N, Sandy R, et al. Common Patterns and Unique Threats in Antimicrobial Resistance as Demonstrated by Global Gonococcal Surveillance. Emerg Infect Dis. 2024. PMID: 39530861. doi:10.3201/eid3014.240296
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。